Fighting Fire with Fire: a Rabies Virus-based Vaccine against Ebola
Loading...
Start Date
9-22-2014 3:50 PM
End Date
9-22-2014 4:15 PM
Description
Presentation: 22 minutes
Dr. Schnell earned the bachelor of science (BS) degree in biology at the University of Stuttgart-Hohenheim, Germany, and subsequently obtained the master of science (MS) degree and doctor of philosophy (PhD) at that same institution. After two-and-a-half years of postdoctoral training at Yale University he came to Jefferson as Assistant Professor of Biochemistry and Molecular Pharmacy and Member, Center for Virology, in 1998. Dr. Schnell was promoted to Associate Professor in 2001 and to Professor of Microbiology and Immunology, Biochemistry and Molecular Pharmacology in 2005. In 2007, he was appointed Director, Jefferson Vaccine Center. At the Center for Human Virology, Dr. Schnell’s research was focused on rabies virus-based vectors and their use to study pathogenicity. As Director, Jefferson Vaccine Center, his current research is largely directed toward developing novel vaccines against emerging infectious diseases. Dr. Schnell is PI on several current and previous foundation and NIH-supported grants, serves on the editorial boards of numerous peer-reviewed journals and has authored over 100 publications.
Fighting Fire with Fire: a Rabies Virus-based Vaccine against Ebola
Presentation: 22 minutes
Dr. Schnell earned the bachelor of science (BS) degree in biology at the University of Stuttgart-Hohenheim, Germany, and subsequently obtained the master of science (MS) degree and doctor of philosophy (PhD) at that same institution. After two-and-a-half years of postdoctoral training at Yale University he came to Jefferson as Assistant Professor of Biochemistry and Molecular Pharmacy and Member, Center for Virology, in 1998. Dr. Schnell was promoted to Associate Professor in 2001 and to Professor of Microbiology and Immunology, Biochemistry and Molecular Pharmacology in 2005. In 2007, he was appointed Director, Jefferson Vaccine Center. At the Center for Human Virology, Dr. Schnell’s research was focused on rabies virus-based vectors and their use to study pathogenicity. As Director, Jefferson Vaccine Center, his current research is largely directed toward developing novel vaccines against emerging infectious diseases. Dr. Schnell is PI on several current and previous foundation and NIH-supported grants, serves on the editorial boards of numerous peer-reviewed journals and has authored over 100 publications.
